Aug 24, 2026 · 1h 13m
Potassium management tests the limits of kidney and heart therapy
#537 Hyperkalemia and Hypokalemia
Potassium abnormalities can signal danger while also forcing clinicians to reconsider medications that protect patients with kidney disease and heart failure.
- 1Confirm unexpected potassium abnormalities before treating them, then sort causes by intake, cellular distribution, and excretion.
- 2Medication, diet, diabetes, magnesium deficiency, and bowel habits can all shape potassium levels across outpatient and dialysis settings.
- 3Potassium binders may preserve beneficial therapies, but cost, access, uncertain outcomes, and dialysis decisions complicate their use.
Don't miss
Joel Topf resolves the persistent hyperkalemia dialysis case by weighing dialysis-bath selection, zirconium cyclosilicate, fiber, and bowel regularity.
The brief
Nephrologist Joel Topf joins Sai Achi and the Curbsiders hosts to build a practical framework for potassium disorders: confirm the result, then examine intake, distribution, and excretion.
For chronic hyperkalemia, the key questions extend beyond kidney function: medications, diabetes, diet, laboratory error, and sodium-potassium physiology can all change the interpretation.
The central clinical tension appears in heart failure, where ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists may raise potassium even as they provide important benefits.
A second case shifts to hypokalemia with severe hypomagnesemia, using urinary magnesium and fractional excretion to distinguish gastrointestinal loss from renal wasting after proton pump inhibitor use.
The dialysis case ends with a deliberately practical balance: consider the dialysis bath, zirconium cyclosilicate, fiber, and bowel regularity while acknowledging the limits of current evidence.
The episode’s durable lesson is not a single potassium target but a repeatable method for confirming abnormalities, finding the cause, and preserving beneficial treatment when possible.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.